In a report released today, David Amsellem from Piper Sandler maintained a Hold rating on Biogen (BIIB – Research Report), with a price target ...
High-rolling investors have positioned themselves bullish on Biogen BIIB, and it's important for retail traders to take note. \This activity came to our attention today through Benzinga's tracking of ...
TD Cowen 45th Annual Health Care Conference March 3, 2025 9:10 AM ETCompany ParticipantsChris Viehbacher - CEOConference ...
StockStory.org on MSN2d
3 Reasons BIIB is Risky and 1 Stock to Buy InsteadShareholders of Biogen would probably like to forget the past six months even happened. The stock dropped 31.4% and now ...
The European Union's medicines regulator on Friday reiterated its positive recommendation for Eisai and Biogen's Alzheimer's ...
Private Advisor Group LLC trimmed its position in Biogen Inc. (NASDAQ:BIIB – Free Report) by 38.9% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange ...
Stocks are freefalling this afternoon, as President Donald Trump's tariffs go into effect and trade partners retaliate ...
After hours: 7:45:25 p.m. EST ...
Build financial models with decades of earnings stats, ratios, and valuation data — all exportable — to power your trade ideas.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback